Eventide Asset Management - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$57,463,546
-22.1%
339,840
-0.0%
1.03%
-17.1%
Q2 2023$73,722,061
+19.4%
339,968
+0.0%
1.25%
+10.0%
Q1 2023$61,739,073
-39.5%
339,898
-34.6%
1.13%
-43.7%
Q4 2022$102,121,050
-12.6%
519,7000.0%2.01%
-12.4%
Q3 2022$116,896,000
+49.2%
519,700
-16.1%
2.30%
+37.2%
Q2 2022$78,360,000
-17.4%
619,400
-17.2%
1.68%
+12.8%
Q1 2022$94,839,000
-3.2%
748,0000.0%1.49%
+18.7%
Q4 2021$97,988,000
+7.1%
748,0000.0%1.25%
+3.7%
Q3 2021$91,503,000
+7.3%
748,0000.0%1.21%
+5.4%
Q2 2021$85,265,000
-27.0%
748,000
-23.0%
1.14%
-33.8%
Q1 2021$116,753,000
+27.5%
971,077
+7.8%
1.73%
+23.2%
Q4 2020$91,540,000
+31.4%
901,0770.0%1.40%
+2.9%
Q3 2020$69,671,000
-30.6%
901,0770.0%1.36%
-37.5%
Q2 2020$100,434,000
+54.8%
901,0770.0%2.18%
+3.9%
Q1 2020$64,878,000
+300.8%
901,077
+319.4%
2.10%
+360.7%
Q4 2019$16,186,000
+235.0%
214,843
-27.4%
0.46%
+185.0%
Q3 2019$4,831,000
-78.1%
296,000
-73.9%
0.16%
-76.2%
Q2 2019$22,060,0001,136,2340.67%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$169,578,43555.90%
Nan Fung Group Holdings Ltd 225,688$48,940,44331.28%
Sofinnova Investments, Inc. 1,381,149$299,502,16119.62%
Paradigm Biocapital Advisors LP 283,605$61,499,7444.75%
First Light Asset Management, LLC 208,746$45,266,5703.55%
Avidity Partners Management LP 442,200$95,891,0703.35%
CATALYST PRIVATE WEALTH, LLC 21,837$4,735,3532.97%
Rock Springs Capital Management LP 493,527$107,021,3302.55%
Boxer Capital, LLC 250,000$54,2132.51%
DAFNA Capital Management LLC 42,173$9,145,2152.50%
View complete list of KARUNA THERAPEUTICS INC shareholders